Medicine & Health

Researchers at Washington University in St. Louis have a developed a way to monitor mouse embryo development and predict successful blastocyst formation. The results of the study could help improve success rates of in vitro fertilization.

WashU’s Prevention Research Center delivered its Evidence-Based Public Health training in Puerto Rico, strengthening local health workforce capacity to tackle chronic disease and limited resources.

WashU Medicine researchers led by Erik Musiek, MD, PhD, discovered in mice that inhibition of a protein that controls the daily cycling of metabolism and inflammation decreases neurodegeneration in Alzheimer’s disease.

WashU Medicine researchers found that immune cells that dispose of the body’s cellular debris can protect insulin-producing cells and prevent Type 1 diabetes in mice.

Funding from the National Science Foundation will enable researchers across many disciplines at Washington University in St. Louis to advance ongoing research into the damaging health effects of repeated flooding in Metro East communities.

Neuroscientists, clinicians and engineers at Washington University in St. Louis seek to develop personalized medicine strategies for refractory depression that would tailor drug dosage based on a patient’s age, genetics, health conditions, brain dynamics and neural circuits.

A multidisciplinary team of researchers at Washington University in St. Louis plans to investigate the neural mechanisms behind various controls of transcutaneous spinal cord stimulation in generating different leg movements with a five-year, nearly $3 million grant the National Institutes of Health (NIH).

A scientist at Washington University in St. Louis has received a grant from the Alzheimer’s Association to support his research investigating the electrochemistry of neurotoxic protein assemblies.

Jeannie Kelly, MD, a renowned expert in the care of women with opiate use disorders during pregnancy, has been named the new director of the Division of Maternal-Fetal Medicine & Ultrasound in the Department of Obstetrics & Gynecology at WashU Medicine.

WashU Medicine researchers received a grant from the National Institutes of Health (NIH) that will help speed development of an enhanced version of naloxone, known by the brand name Narcan.